Sensus Healthcare (SRTS) Non-Current Deffered Revenue (2015 - 2026)
Sensus Healthcare's (SRTS) quarterly Non-Current Deffered Revenue came in at $4000.0 in Q1 2026, down 90.7% year-on-year from $43000.0 in Q1 2025, and down 60.0% quarter-over-quarter from $10000.0 in Q4 2025.
Sensus Healthcare (SRTS) Non-Current Deffered Revenue (2015 - 2026) Analysis & Trends
Sensus Healthcare's Non-Current Deffered Revenue history runs 12 years deep, the most recent figure standing at $4000.0 for Q1 2026.
- On a quarterly basis, Non-Current Deffered Revenue fell 90.7% year-over-year to $4000.0 in Q1 2026; TTM through Mar 2026 was $4000.0, a 90.7% decrease from a year earlier, with the FY2025 full-year figure at $10000.0, down 81.82% from the prior year.
- Non-Current Deffered Revenue eased to $4000.0 in Q1 2026 per SRTS's latest filing, from $10000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $236000.0 in Q1 2022 and bottomed at $4000.0 in Q1 2026.
- The 5-year median for Non-Current Deffered Revenue is $66000.0 (2024), against an average of $86058.8.
- Across the five-year window, Non-Current Deffered Revenue climbed 7.5% in 2025 and sank 90.7% in 2026, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $139000.0 in 2022, then sank by 56.83% to $60000.0 in 2023, then retreated by 8.33% to $55000.0 in 2024, then sank by 81.82% to $10000.0 in 2025, then sank by 60.0% to $4000.0 in 2026.
- Per Business Quant, the three latest SRTS Non-Current Deffered Revenue figures stand at $4000.0 (Q1 2026), $10000.0 (Q4 2025), and $21000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | 4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 77,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 60,000.00 |
| Sep 30, 2023 | 80,000.00 |
| Jun 30, 2023 | 116,000.00 |
| Mar 31, 2023 | 126,000.00 |
| Dec 31, 2022 | 139,000.00 |
| Sep 30, 2022 | 172,000.00 |
| Jun 30, 2022 | 186,000.00 |
| Mar 31, 2022 | 236,000.00 |
| Dec 31, 2021 | 262,000.00 |
| Sep 30, 2021 | 246,000.00 |
| Jun 30, 2021 | 334,000.00 |